These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11551001)

  • 1. Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey.
    Brown DW; Giles WH; Greenlund KJ; Valdez R; Croft JB
    J Cardiovasc Risk; 2001 Aug; 8(4):227-33. PubMed ID: 11551001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum glucose and insulin are associated with QTc and RR intervals in nondiabetic elderly.
    van Noord C; Sturkenboom MC; Straus SM; Hofman A; Kors JA; Witteman JC; Stricker BH
    Eur J Endocrinol; 2010 Feb; 162(2):241-8. PubMed ID: 19897609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).
    Muntner P; He J; Chen J; Fonseca V; Whelton PK
    Ann Epidemiol; 2004 Oct; 14(9):686-95. PubMed ID: 15380800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QTc duration is associated with levels of insulin and glucose intolerance. The Zutphen Elderly Study.
    Dekker JM; Feskens EJ; Schouten EG; Klootwijk P; Pool J; Kromhout D
    Diabetes; 1996 Mar; 45(3):376-80. PubMed ID: 8593946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.
    Unwin N; Shaw J; Zimmet P; Alberti KG
    Diabet Med; 2002 Sep; 19(9):708-23. PubMed ID: 12207806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of long-term glycaemic variability versus sustained chronic hyperglycaemia with heart rate-corrected QT interval in patients with type 2 diabetes.
    Su JB; Yang XH; Zhang XL; Cai HL; Huang HY; Zhao LH; Xu F; Chen T; Cheng XB; Wang XQ; Lu Y
    PLoS One; 2017; 12(8):e0183055. PubMed ID: 28846720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey.
    Benoit SR; Mendelsohn AB; Nourjah P; Staffa JA; Graham DJ
    Eur J Cardiovasc Prev Rehabil; 2005 Aug; 12(4):363-8. PubMed ID: 16079644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of glomerular hyperfiltration in subjects with impaired glucose tolerance and newly diagnosed diabetes.
    Sun ZJ; Yang YC; Wu JS; Wang MC; Chang CJ; Lu FH
    Nephrol Dial Transplant; 2016 Aug; 31(8):1295-301. PubMed ID: 26610595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.
    Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R
    Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program.
    Rodriguez BL; Curb JD; Burchfiel CM; Huang B; Sharp DS; Lu GY; Fujimoto W; Yano K
    Diabetes Care; 1996 Jun; 19(6):587-90. PubMed ID: 8725856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of different glucose tolerance on QTc interval: a population-based study.
    Lin N; Zhang H; Li X; Niu Y; Gu H; Lu S; Yang Z; Su Q; Qin L
    BMC Cardiovasc Disord; 2023 Jan; 23(1):47. PubMed ID: 36698056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of plasma glucose and electrocardiographic parameters in elderly women with different degrees of glucose tolerance.
    Solini A; Passaro A; D'Elia K; Calzoni F; Alberti L; Fellin R
    Aging (Milano); 2000 Aug; 12(4):249-55. PubMed ID: 11073343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
    Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
    Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
    Tominaga M; Eguchi H; Manaka H; Igarashi K; Kato T; Sekikawa A
    Diabetes Care; 1999 Jun; 22(6):920-4. PubMed ID: 10372242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of diabetes and impaired fasting glucose in Costa Rica: Costa Rican National Cardiovascular Risk Factors Survey, 2010.
    Wong-McClure R; Gregg EW; Barcelo A; Sanabria-Lopez L; Lee K; Abarca-Gomez L; Cervantes-Loaiza M; Luman ET
    J Diabetes; 2016 Sep; 8(5):686-92. PubMed ID: 26516694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart rate-corrected QT interval is an independent predictor of all-cause and cardiovascular mortality in individuals with type 2 diabetes: the Diabetes Heart Study.
    Cox AJ; Azeem A; Yeboah J; Soliman EZ; Aggarwal SR; Bertoni AG; Carr JJ; Freedman BI; Herrington DM; Bowden DW
    Diabetes Care; 2014 May; 37(5):1454-61. PubMed ID: 24574343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT interval prolongation and the risks of stroke and coronary heart disease in a general Japanese population: the Hisayama study.
    Maebuchi D; Arima H; Doi Y; Ninomiya T; Yonemoto K; Tanizaki Y; Kubo M; Hata J; Matsumura K; Iida M; Kiyohara Y
    Hypertens Res; 2010 Sep; 33(9):916-21. PubMed ID: 20535120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolongation of the QTc interval is associated with an increased risk of cardiovascular diseases: The Hoorn study.
    Welten SJGC; van der Heijden AA; Remmelzwaal S; Blom MT; Nijpels G; Rutters F; Beulens JWJ; Elders PJM;
    J Electrocardiol; 2023; 80():133-138. PubMed ID: 37352635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.